Pancreatic Cancer, Diabetes, and Endocrine Health: What You Need to Know

Managing Diabetes in Pancreatic Cancer: The Role of Oncoendocrinology

Pancreatic cancer and diabetes are closely linked due to the pancreas’ role in insulin production. Cancer treatments—including chemotherapy, immunotherapy, radiation, and surgery—can further disrupt blood sugar levels and damage endocrine organs like the thyroid and adrenal glands.

Dr. Afreen Shariff, director of the Duke Endo-Oncology Program and co-founder of Citrus Oncology, emphasizes the need for endocrinologists on pancreatic cancer care teams. Worsening diabetes control can signal pancreatic cancer, yet symptoms like fatigue, thirst, and weight loss are often overlooked. Cancer treatments and steroids can also cause blood sugar spikes, requiring tailored insulin management.

A lesser-known form, Type 3c diabetes, results from pancreatic damage and differs from Type 1 and Type 2, making management complex. Endocrinologists specializing in oncoendocrinology help adjust treatment based on evolving patient needs. Given diabetes’ data-driven nature, remote monitoring and virtual consultations can ensure optimal care for cancer patients.

https://letswinpc.org/disease-management/life-during-treatment/side-effect-management-matters/